BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/4/2021 1:47:10 PM | Browse: 591 | Download: 1005
 |
Received |
|
2020-12-28 21:11 |
|
Peer-Review Started |
|
2020-12-28 21:12 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-01-11 01:19 |
|
Revised |
|
2021-01-22 23:24 |
|
Second Decision |
|
2021-03-15 04:38 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-03-18 16:07 |
|
Articles in Press |
|
2021-03-18 16:07 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-05-07 13:40 |
|
Typeset the Manuscript |
|
2021-05-25 09:48 |
|
Publish the Manuscript Online |
|
2021-06-04 13:47 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Review |
| Article Title |
Role of novel biomarkers in diabetic cardiomyopathy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Marko Kumric, Tina Ticinovic Kurir, Josip A Borovac and Josko Bozic |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Josko Bozic, MD, PhD, Associate Professor, Department of Pathophysiology, University of Split School of Medicine, Soltanska 2, Split 21000, Croatia. josko.bozic@mefst.hr |
| Key Words |
Diabetic cardiomyopathy; Heart failure; Biomarkers; Diabetes mellitus; Cardiomyopathy |
| Core Tip |
Affecting 12% of diabetics, diabetic cardiomyopathy (DCM) is an under-recognized and lethal complication of diabetes. This urges the need for reliable and available biomarker for DCM detection. So far none of the conducted studies have been successful on this topic. Hence, in concordance with current guidelines that accentuate the importance of interdisciplinary team-based approach, we proposed a combination of speckle tracking echocardiography and few novel biomarkers as a screening method for DCM in patients with newly onset Diabetes mellitus type 2. |
| Publish Date |
2021-06-04 13:47 |
| Citation |
Kumric M, Ticinovic Kurir T, Borovac JA, Bozic J. Role of novel biomarkers in diabetic cardiomyopathy. World J Diabetes 2021;12(6): 685-705 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i6/685.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i6.685 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
